Company Profile
Sage Therapeutics, Inc. Stock Price, News & Catalysts
- Ticker:
- SAGE
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for SAGE.
Company overview
Business overview
Sage Therapeutics is a neuroscience company focused on neuropsychiatry, depression, and other CNS disorders.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Sage sits in specialty neuroscience biotech.
Business Model Characteristics
The company combines commercial execution around CNS medicines with ongoing development in brain-health programs.
Position Within the Biotechnology Landscape
Sage is a CNS catalyst name whose stock tends to move sharply on clinical, commercial, and partnership developments.
Future catalysts
- Sage Therapeutics's catalysts are ZURZUVAE commercialization economics and any next-step CNS update that clarifies whether the company still has a growth path after the reset. The stock remains highly sensitive to whether the launch base can stabilize.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Sage Therapeutics, Inc. do?
Sage Therapeutics is a neuroscience company focused on neuropsychiatry, depression, and other CNS disorders.
On which exchange is SAGE stock listed?
Sage Therapeutics, Inc. (SAGE) is associated with NASDAQ, United States, Biopharma.
What is Sage?
Sage Therapeutics's catalysts are ZURZUVAE commercialization economics and any next-step CNS update that clarifies whether the company still has a growth path after the reset.
Which conditions is Sage Therapeutics, Inc. targeting with Sage?
Sage Therapeutics, Inc. is associated with neuroscience based on its company overview and current catalyst commentary.
How does Sage Therapeutics, Inc. describe recent progress with Sage?
Sage Therapeutics's catalysts are ZURZUVAE commercialization economics and any next-step CNS update that clarifies whether the company still has a growth path after the reset.
What is Therapeutics?
Sage Therapeutics is a neuroscience company focused on neuropsychiatry, depression, and other CNS disorders.
What should investors watch for with Therapeutics?
Sage Therapeutics's catalysts are ZURZUVAE commercialization economics and any next-step CNS update that clarifies whether the company still has a growth path after the reset.
What future catalysts are investors watching for Sage Therapeutics, Inc.?
Sage Therapeutics's catalysts are ZURZUVAE commercialization economics and any next-step CNS update that clarifies whether the company still has a growth path after the reset. The stock remains highly sensitive to whether the launch base can stabilize.